ADMA (NASDAQ) - ADMA Biologics Inc
Exchange: USA Stocks • Country: USA • Currency: USD • Type: Common Stock • ISIN: US0008991046
https://www.admabiologics.com
ADMA Biologics, Inc., a biopharmaceutical company, engages in developing, manufacturing, and marketing specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally. It offers BIVIGAM, an intravenous immune globulin (IVIG) product indicated for the treatment of primary humoral immunodeficiency (PI); ASCENIV, an IVIG product for the treatment of PI; and Nabi-HB for the treatment of acute exposure to blood containing Hepatitis B surface antigen and other listed exposures to Hepatitis B. The company also develops a pipeline of plasma-derived therapeutics, including products related to the methods of treatment and prevention of S. pneumonia infection for an immunoglobulin. In addition, it operates source plasma collection facilities. The company sells its products through independent distributors, drug wholesalers, specialty pharmacies, and other alternate site providers. ADMA Biologics, Inc. was incorporated in 2004 and is headquartered in Ramsey, New Jersey. Web URL: Drawdown (Underwater) Chart

External Links for ADMA (NASDAQ) - ADMA Biologics Inc
Warnings
- Uncommon Growth Rate
Market Cap. | 905m USD |
GiC Sector | Health Care |
GiC Industry | Biotechnology |
GiC SubIndustry | Biotechnology |
TER | 0.00% |
IPO / Inception | 2013-10-17 |
Ratings
Fundamental | -2.74 |
Dividend | - |
Performance 5y | -0.49 |
Performance TTM | 2.50 |
Relative Performance | 2.35 |
Analysts | 4.67 |
Price / Fair Price TR | 1.17 |
Price / Fair Price DCF | todo |
Technical
Growth TTM | 84.65% |
CAGR 5y | -3.08% |
CAGR / Mean Drawdown 5y | -0.06 |
Sharpe Ratio TTM | 1.33 |
Alpha vs SP500 TTM | 80.05 |
Beta vs SP500 5y weekly | 0.75 |
CAPM | 8.70% |
Average Daily Range % | 4.27% |
Volatility GJR Garch 1y | 51.41% |
Max Drawdown 5y | 84% |
Mean Drawdown 5y | 54.4% |
Price / SMA 50 | 9.37% |
Price / SMA 200 | 21.41% |
Current Volume | 1047k |
Average Volume | 2350.7k |
Dividends
Rate TTM | 0.00 |
Yield TTM | 0.00% |
Div. CAGR 5y | 0.00% |
Consistency of Dividends all time | 0.0% |